Figure 4
From: DAC can restore expression of NALP1 to suppress tumor growth in colon cancer
The staging and survival analyses. (a) T test of NALP1 expression in tumor tissue between stage I/II and stage III/IV disease. The expression of NALP1 in stage I/II was significantly higher than stage III/IV disease (P=0.0465). (b) T test of NALP1 in paratumoral tissue between stage I/II and stage III/IV disease revealed no significant difference (P=0.2418). (c) Survival analysis of 33 cases. There was no significant difference between the two groups. HTN, higher tumor NALP1; LTN, lower tumor NALP1. The P-value was 0.6443. (d) Survival analysis of 33 cases. The difference between the two groups is significant. HPN, higher paratumoral NALP1; LPN, lower paratumoral NALP1. The P-value was 0.0199
